- Elizabeth Arden, Inc. RDEN shares surged 48.76 percent to $13.85 as Revlon Inc REV agreed to acquire the company for $14.00 per share in cash, for an enterprise value of around $870 million.
- Southeastern Bank Financial Corp SBFC shares climbed 35.74 percent to $46.56. South State Corporation SSB and Southeastern Bank Financial reported that they have entered into a merger agreement.
- Lumber Liquidators Holdings Inc LL shares jumped 22 percent to $16.14 following Thursday announcement of agreement with the U.S. Consumer Products Safety Commission regarding laminate flooring products made in China. Lumber Liquidators agreed to not resume sales of laminate wood flooring previously imported from China.
- BioScrip Inc BIOS surged 19.57 percent to $2.47. BioScrip priced its 40 million share offering at $2.00 per share.
- Teekay Offshore Partners L.P. TOO shares rose 18.68 percent to $5.40. Teekay Offshore reported a $200 million private placement.
- Sky Solar Holdings Ltd (ADR) SKYS shares climbed 12.77 percent to $3.62. Sky Solar Holdings reported a loss of $823 thousand or a low of $0.002 per share in the first quarter compared to a net income of $2.6 million or $0.01 per share in the year-ago quarter. Street estimated a loss of $0.06 a share.
- Smith & Wesson Holding Corp SWHC gained 7.63 percent to $23.41 as the company posted upbeat results for its fourth quarter and issued a strong forecast for the year.
- Finisar Corporation FNSR shares climbed 7.45 percent to $18.89 as the company reported better-than-expected earnings for its fourth quarter and issued strong earnings guidance for the current quarter.
- Paratek Pharmaceuticals Inc PRTK gained 7 percent to $17.57. Paratek reported that Omadacycline has met all primary and secondary efficacy outcomes designated by the FDA and EMA in a Phase 3 study in acute bacterial skin infections
- Lifelock Inc LOCK shares gained 4 percent to $15.58 as Elliott Associates reported a 5.1 percent stake in LifeLock.
- Oracle Corporation ORCL rose 3 percent to $39.67. Oracle reported stronger-than-expected revenue for its fourth quarter, but missed analysts’ earnings estimates.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
